Cell and Gene Therapy Insights Webinars

CELL AND GENE THERAPY INSIGHTS

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

A Frazer, L R. Salvitti, S Lovatt et al

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Jens Björkman, Andreas Hecker

Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Spot-on, standard-free AAV titer and characterization with Stunner

Spot-on, standard-free AAV titer and characterization with Stunner

Turbocharging pDNA production: a case study on optimization through novel technologies

Turbocharging pDNA production: a case study on optimization through novel technologies

Xiangming Gu, Lucas Smith

Find the EV needle in the haystack with Leprechaun

Find the EV needle in the haystack with Leprechaun

Navigating the transition from research to clinical-scale cell therapy manufacture

Navigating the transition from research to clinical-scale cell therapy manufacture

Steven Feldman, Johannes Fruehauf, Mary Ann Santos

Case study: establishing a versatile and intensified lentiviral vector production platform with TFDF

Case study: establishing a versatile and intensified lentiviral vector production platform with TFDF

Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

K Bruce, K Bharti, I Barbaric et al

Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

Olaf Stamm, Horst Ruppach

Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Dan Oliver, Ji Hyun Lee

Armor CAR T cells with enhanced potency for cancer immunotherapy

Armor CAR T cells with enhanced potency for cancer immunotherapy

Conducting rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

Conducting rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

M Dingle, A Carwell, M J. Miller et al

Fit-for-purpose analytical development for an emerging cell therapy landscape

Fit-for-purpose analytical development for an emerging cell therapy landscape

Jie Wei, Damian Marshall, Florian Durst

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

John Bowen, Brian Tomkowicz

Cost reduction of viral vector processes using 3D nanofiber-based cell culture systems in upstream bioprocessing

Cost reduction of viral vector processes using 3D nanofiber-based cell culture systems in upstream bioprocessing

Rob Noel, Geddy Hamblen, Christel Fenge

1
2
3
4
5
6
7
8
9
10
...
>
>>